Board of Directors

Ido Schoenberg serves as the Chairman and CEO of Amwell and oversees the company’s corporate strategy. Since co-founding the company in 2006, with Roy Schoenberg, Ido has led its strategic direction, growing Amwell to become one of the largest digital care enablement companies in the world. Ido has a lengthy track record of successfully leading technology companies in the healthcare field. In 1996, together with Phyllis Gotlib, he co-founded iMDSoft, a provider of enterprise software that automates hospital critical care units. He grew the company into a market leader with a large multi-national install base in the U.S., Europe, and East Asia. In 2001, Ido joined CareKey Inc. as Chief Executive Officer and took the company through its acquisition by the TriZetto group. Ido served as TriZetto’s Chief Business Strategy Officer until his departure in the summer of 2006. Ido received his MD from the Sackler School of Medicine.

Roy Schoenberg is Amwell's Executive Vice Chairman. Since co-founding the company with his brother, Ido, in 2006 and taking it public in 2020, Amwell has become one of the world’s largest digital networks, helping patients, clinicians and payers welcome a new world of tech-enabled healthcare. 

Outside of Amwell, Roy is on the advisory board of the MIT Sloan Health Initiative, Brigham and Women’s Hospital Center for Patient Safety Research and Practice, the American Heart Association Telehealth board, and Modern Healthcare has repeatedly recognized him as one of the 100 Most Influential People in Healthcare. Roy is a former American Telemedicine Association board member, and the organization has recognized him for his industry leadership. He continues to see innovation in digital care as his calling, holding more than 50 U.S.-issued patents in this domain. 

Roy holds an M.D. from The Hebrew University and an M.P.H. from Harvard. He lives in Boston with his wife and two children. 

Toby Cosgrove, MD, is former CEO and president of Cleveland Clinic. Serving from 2004 through 2017, he led the $8 billion organization to new heights of achievement and efficiency, seeing it ranked the #2 hospital in America (U.S. News). He currently serves as Executive Advisor, working with Cleveland Clinic leadership on strategies for national and international growth.

Dr. Cosgrove graduated from Williams College and the University of Virginia School of Medicine. He trained at Massachusetts General Hospital and Brook General Hospital in London. In 1967, he was a surgeon in the U.S. Air Force, earning a Bronze Star.

Dr. Cosgrove joined Cleveland Clinic in 1975, and chaired the Department of Thoracic and Cardiovascular surgery from 1989 to 2004. He performed over 22,000 operations and earned an international reputation in valve repair He holds 30 patents for medical innovations. As CEO from 2004 to 2017, he reorganized services, improved outcomes and patient experience, and strengthened the organization’s finances.

He is a member of the National Academy of Medicine, and a Fellow of the National Academy of Inventors. In 2016, he was a Fortune Businessperson of the Year (No. 14). Three successive presidents of the United States have consulted him on healthcare issues.

In 2011, Deborah C. Jackson became the President of Cambridge College, bringing to the institution decades of leadership expertise from a number of Boston’s leading institutions. She had previously served for nearly a decade as CEO of the American Red Cross of Eastern Massachusetts. Prior to that, she was vice president of the Boston Foundation and senior vice president at Boston Children’s Hospital. She spent a decade early in her career at one of the country’s leading research and consulting firms, Abt Associates, where she served as the Deputy Director of its Healthcare and Income Security Group.

Throughout her career, Ms. Jackson has served on numerous boards and commissions including serving on the Mayor’s Task Force on Healthcare Disparities as Co‑Chair, the Group Insurance Commission of the Commonwealth of Massachusetts, the Board of Directors of Harvard Pilgrim Health Care, and the National Association of Corporate Directors. She currently serves as the Lead Director of Eastern Bank Corporation and is a board member of the Eastern Bank Charitable Foundation and serves on the boards of John Hancock Investments and the Massachusetts Women’s Forum.

Ms. Jackson attended Hampton University and completed her undergraduate studies at Northeastern University. She attended graduate school at the Massachusetts Institute of Technology in the Department of Urban Studies and Planning and attended the Harvard University Advanced Leadership Institute. She is the recipient of honorary doctorate degrees from Curry College and Merrimack Valley College.

Ricky Goldwasser is an experienced financial executive with over 20 years of experience advising healthcare organizations and institutional investors. She spent 15 years at Morgan Stanley where she was a managing director, head of U.S. Healthcare Services & Technology Research and most recently Investment Banking groups, and was formally co-head of U.S. Healthcare Research at UBS where she covered healthcare services, diagnostics, and generic companies.

Throughout her career, she has led many successful initial public offerings, including Amwell, and has a passion for helping companies navigate the complexities of public market dynamics. She has been recognized by Institutional Investor Magazine as a top-ranked research analyst for 18 years. Ricky received her bachelor’s degree in Economics and Political Science from Tel Aviv University and her MBA from the Kellogg School of Management at Northwestern University.

Derek Ross serves as the Business Leader of Philips Population Health Management. Prior to this role, Derek led the finance organizations for both Philips informatics business groups - Healthcare Informatics and Population Health Management. Derek began his 17 years at Philips as part of the Agilent Healthcare acquisition. During his tenure at Philips, Derek has held various global leadership roles and led the integration of several early stage growth businesses acquisitions. He began his professional career in the investment community at Neuberger Berman.

Derek received his Bachelor of Science degree in Accounting and Information Systems from Babson College and holds an MBA from the F.W. Olin Graduate School of Business at Babson College.

Stephen J. Schlegel is Vice President, Corporate Development at Anthem. Steve is responsible for leading the company’s corporate development activities, managing mergers and acquisitions, including valuation analysis, executing due diligence, and corporate negotiations.

Prior to joining Anthem in 2005, Steve was the Vice President of Corporate Development with Sprint and acting Vice President of Corporate Strategy. At Sprint, Steve participated in the development of the corporation’s strategic direction and played an essential role in Sprint’s merger with Nextel.

Steve earned an MBA in finance from the University of Chicago and a BA in accounting from Loras College in Dubuque, Iowa.

Peter L. Slavin, MD became the President of Massachusetts General Hospital on January 1, 2003. From 1999-2002, he served as Chairman and Chief Executive Officer of the Massachusetts General Physicians Organization, which included over 1,700 physicians and employed nearly 1,000 of them.

From 1997 to 1999, Slavin served as President of Barnes-Jewish Hospital in St. Louis, Missouri. Before that, he did his training in Internal Medicine at Massachusetts General Hospital from 1984 to 1987 and was Senior Vice President and Chief Medical Officer from 1994 to 1997.

Slavin graduated from Harvard College in 1979, Harvard Medical School in 1984, and Harvard Business School in 1990.

Slavin teaches internal medicine and health care management at Harvard Medical School where he is a Professor of Health Care Policy.

He serves on the Board of the Association of American Medical Colleges.

Rob Webb is a seasoned health care executive, board member, and a passionate advocate for innovation in established industries. With a distinguished 19-year tenure at UnitedHealth Group, Rob held several key executive positions, including a decade as CEO of Optum’s consumer and specialty network businesses, and nine years as president of UHG Ventures. Currently, he leads Onward Enterprises, an investment and advisory firm dedicated to fostering innovation in health care and beyond.

In addition to the Amwell board, Rob serves on the boards of Ardent Health, Delmec Ireland, and The Kellogg School Health Care Advisory Board. His board experience extends to dynamic, high-growth health care companies such as Collage Rehabilitation Partners, Symphonix Health, Sanvello, Naviguard, Bind Insurance (now Surest), Level2, among others.

He holds a bachelor’s degree in mechanical engineering from the University of Minnesota and an MBA in finance from the Kellogg School of Management at Northwestern University.